Filing Details

Accession Number:
0001437749-23-015335
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-05-19 17:53:37
Reporting Period:
2023-05-18
Accepted Time:
2023-05-19 17:53:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1434647 Zevra Therapeutics Inc. ZVRA Pharmaceutical Preparations (2834) 205894398
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1612084 B John Bode C/O Zevra Therapeutics, Inc.
1180 Celebration Boulevard, Suite 103
Celebration FL 34747
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-05-18 1,390 $5.04 1,390 No 4 P Direct
Common Stock Acquisiton 2023-05-18 300 $5.04 1,690 No 4 P Direct
Common Stock Acquisiton 2023-05-18 1,000 $5.04 2,690 No 4 P Direct
Common Stock Acquisiton 2023-05-18 4,759 $5.04 7,449 No 4 P Direct
Common Stock Acquisiton 2023-05-18 100 $5.05 7,549 No 4 P Direct
Common Stock Acquisiton 2023-05-18 2,451 $5.05 10,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct